Hypertensive Qin19 2016 All-cause mortality Continuous SUA level 3 NA NA aHR Random 1.05 (0.98, 1.13) patients Other outcomes Trkulja ADDIN EN.CITE Medium/long-term occurrence of poor Highest vs lowest SUA 2012 AMI patients 3 2,683 NA HR Random 1.30 (1.01, 1.68) outcomes category (death/MACE) Trkulja ADDIN EN.CITE Medium/long-term occurrence of poor μmol/L 2012 AMI patients 4 3,533 NA aHR Random 1.19 (1.03, 1.37) 50 increase outcomes (death/MACE) Trkulja ADDIN EN.CITE Short-term occurrence of poor Highest vs lowest SUA 2012 AMI patients 4 3,625 336 aOR Random 2.26 (1.85, 2.77) outcomes category (death/MACE)
Qin19 2016 All-cause mortality Hypertensive patients Continuous SUA level 3 NA NA aHR Random 1.05 (0.98, 1.13) Other outcomes Trkulja ADDIN EN.CITE 2012 Medium/long-term occurrence of poor outcomes (death/MACE) AMI patients Highest vs lowest SUA category 3 2,683 NA HR Random 1.30 (1.01, 1.68) Trkulja ADDIN EN.CITE 2012 Medium/long-term occurrence of poor outcomes (death/MACE) AMI patients 50 μmol/L increase 4 3,533 NA aHR Random 1.19 (1.03, 1.37) Trkulja ADDIN EN.CITE 2012 Short-term occurrence of poor outcomes (death/MACE) AMI patients Highest vs lowest SUA category 4 3,625 336 aOR Random 2.26 (1.85, 2.77)